Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J1411 is classified under Drugs Administered Other than Oral Method, in the Drugs, Administered by Injection subgroup.
| Key Fact | Detail |
|---|---|
| Service Type | Drugs Administered Other than Oral Method Drugs, Administered by Injection |
| Common Place of Service | 22On Campus Outpatient Hospital |
| Hospital Outpatient Group (APC) | APC 9138 - Inj, hemgenix, per tx dose |
| Medicaid Fee Schedule | $3,500,000.00 median of the 5 states in the free previewView Medicaid rates for J1411 |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 00053010010 - HEMGENIX (etranacogene dezaparvovec), kit • 00053011011 - HEMGENIX (etranacogene dezaparvovec), kit • 00053012012 - HEMGENIX (etranacogene dezaparvovec), kit • 00053013013 - HEMGENIX (etranacogene dezaparvovec), kit • 00053014014 - HEMGENIX (etranacogene dezaparvovec), kit |
National average reimbursement for HCPCS J1411 by major payers:

$2,451,527.43
BCBS / Anthem

$2,074,368.86
UnitedHealthcare

$49.42
Aetna

$N/A
Cigna
Choose a payer to see a sample of rates for HCPCS J1411.
Northside Hospital, Inc., Northside Hospital
Northside Hospital Inc
Catherine Lee
Columbus Arthritis Center
Vhs Huron Valley-Sinai Hospital Inc, Huron Valley-Sinai Hospital
Adventist Health System-Sunbelt, Inc, Adventhealth Orlando
Adventist Health System-Sunbelt Inc
Dlp Harris Regional Hospital LLC, Harris Regional Hospital
Choose your state and specialty to build a report from payer-published rates.
Looking for other data?
Rate Benchmarking
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonPayer Contract Negotiation
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J1411 vs. Other Drugs, Administered by Injection Codes
The table lists codes related to J1411. Select one to see its fee schedule.
| Code | Description |
|---|---|
| 00053010010-NDC | HEMGENIX (etranacogene dezaparvovec), kit |
| 00053011011-NDC | HEMGENIX (etranacogene dezaparvovec), kit |
| 00053012012-NDC | HEMGENIX (etranacogene dezaparvovec), kit |
| J1411-HCPCS | Injection, etranacogene dezaparvovec-drlb, per therapeutic dose |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J1411. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J1411 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
Bring your top codes (like HCPCS J1411) and we'll show you how you compare in 15 minutes or less.
Medicare's hospital outpatient payment system (OPPS) assigns HCPCS J1411 to APC 9138 (Inj, hemgenix, per tx dose). An APC groups outpatient services that Medicare pays at the same base rate.